APA (7th ed.) Citation

N, M., E, K., TM, B., K, M., KL, C., KA, L., . . . YG, S. (2024). MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease, 15(3), 198. https://doi.org/10.1038/s41419-024-06524-w

Chicago Style (17th ed.) Citation

N, Mukherjee, et al. "MCL1 Inhibition Targets Myeloid Derived Suppressors Cells, Promotes Antitumor Immunity and Enhances the Efficacy of Immune Checkpoint Blockade." Cell Death & Disease 15, no. 3 (2024): 198. https://doi.org/10.1038/s41419-024-06524-w.

MLA (9th ed.) Citation

N, Mukherjee, et al. "MCL1 Inhibition Targets Myeloid Derived Suppressors Cells, Promotes Antitumor Immunity and Enhances the Efficacy of Immune Checkpoint Blockade." Cell Death & Disease, vol. 15, no. 3, 2024, p. 198, https://doi.org/10.1038/s41419-024-06524-w.